blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0230119

EP0230119 - Cloning, characterization and expression of bovine gamma interferon [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.11.1989
Database last updated on 03.09.2024
Most recent event   Tooltip07.07.2007Change - inventorpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
IMMUNEX CORPORATION
51 University Building Suite 600 Seattle
Washington 98101 / US
[N/P]
Former [1987/31]For all designated states
IMMUNEX CORPORATION
51 University Building Suite 600
Seattle Washington 98101 / US
Inventor(s)01 / Baker, Paul E.
16710 Agate Pass Road
Bainbridge Island Washington 98110 / US
02 / Cerretti, Douglas Pat
1607 North 197th Place
Seattle Washington 98133 / US
03 / Cosman, David J.
116 11th Avenue East, No. 501
Seattle Washington 98102 / US
04 / McKereghan, Kate N.
8830 233rd Place Southwest
Edmonds Washington 98020 / US
[1987/31]
Representative(s)Sheard, Andrew Gregory, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
[N/P]
Former [1987/31]Sheard, Andrew Gregory, et al
Kilburn & Strode 30, John Street
London WC1N 2DD / GB
Application number, filing date86309440.504.12.1986
[1987/31]
Priority number, dateUS1985080481504.12.1985         Original published format: US 804815
[1987/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0230119
Date:29.07.1987
Language:EN
[1987/31]
Search report(s)(Supplementary) European search report - dispatched on:EP19.05.1987
ClassificationIPC:C12N15/00, C07H21/04, C12N1/20, C07K15/26, C12P21/00
[1987/31]
CPC:
A61P31/12 (EP); C07K14/57 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1987/31]
TitleGerman:Klonierung, Charakterisierung und Expression von Rinder-gamma-Interferon[1987/31]
English:Cloning, characterization and expression of bovine gamma interferon[1987/31]
French:Clonage, caractérisation et expression de gamma-interféron bovin[1987/31]
Biological materialThis application mentions deposited biological material, check the file for details
File destroyed:24.07.1995
MiscellaneousEPB 1987/31: A request for correction of Fig. 1 and page 17 of the description has been filed pursuant to Rule 88 EPC. A decision on the request will be taken during the proceedings before the Examining Division
Examination procedure18.01.1988Examination requested  [1988/12]
04.07.1989Application deemed to be withdrawn, date of legal effect  [1990/01]
04.08.1989Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1990/01]
Fees paidPenalty fee
Additional fee for renewal fee
02.01.198903   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchEP0088622  [ ] (GENENTECH INC [US])
 [XP]  - CHEMICAL ABSTRACTS, vol. 105, no. 9, September 1, 1986, Columbus, Ohio, USA D.P.CERRETTI et al. "Cloning, sequence and expression of bovine interferon-gamma" page 167, column 2, abstract-no. 73 588u
 [XP]  - CHEMICAL ABSTRACTS, vol. 104, no. 17, April 28, 1986, Columbus, Ohio, USA M.J.STEINBECK et al. "Activation of bovine neutrophils by recombinant interferon-gamma" page 526, column 2, abstract-no. 146 897k
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.